MYRIAD GENETICS INC (MYGN) Institutional Ownership and Insiders Activity
MYRIAD GENETICS INC (MYGN) is widely held by institutional investors, with 192 firms reporting positions valued at approximately $505.90M based on SEC Form 13F filings for the quarter ended June 30, 2026.
Blackrock, Inc. is the largest disclosed holder, reporting approximately $62.18M in MYGN holdings in its latest filing.
Recent insider activity includes 4 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
192
Total Reported Value
$505.90M
Largest Holder
Blackrock, Inc.
Largest Position
$62.18M
Insider Transactions (90d)
4
Latest Filing Quarter
Q2 2026
New Institutional Positions
45
Funds Exiting Positions
53
Top Institutional Owners
View allInvestorReported Balance
- Blackrock, Inc.$62.18M
- Millennium Management Llc$37.80M
- Vestal Point Capital, Lp$32.75M
- State Street Corp$28.46M
- D. E. Shaw & Co., Inc.$26.16M
Related MYGN Institutional Insights:
- MYGN 13F Institutional Holders
- MYGN Superinvestors
- MYGN Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- MYGN Insider Trading & SEC Form 4 Activity
- MYGN Articles
- Top Institutional Investor Stock Rankings